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Abstract
Nucleic acid-based aptamers offer many potential advantages relative to antibodies and other protein-based affinity
reagents, including facile chemical synthesis, reversible folding, improved thermal stability and lower cost. However, their
selection requires significant time and resources and selections often fail to yield molecules with affinities sufficient for
molecular diagnostics or therapeutics. Toward a selection technique that can efficiently and reproducibly generate high
performance aptamers, we have developed a microfluidic selection process (M-SELEX) that can be used to obtain high
affinity aptamers against diverse protein targets. Here, we isolated DNA aptamers against three protein targets with
different isoelectric points (pI) using a common protocol. After only three rounds of selection, we discovered novel aptamer
sequences that bind to platelet derived growth factor B (PDGF-BB; pI=9.3) and thrombin (pI=8.3) with respective
dissociation constants (Kd) of 0.028 nM and 0.33 nM, which are both superior to previously reported aptamers against these
targets. In parallel, we discovered a new aptamer that binds to apolipoprotein E3 (ApoE; pI=5.3) with a Kd of 3.1 nM.
Furthermore, we observe that the net protein charge may exert influence on the affinity of the selected aptamers. To further
explore this relationship, we performed selections against PDGF-BB under different pH conditions using the same selection
protocol, and report an inverse correlation between protein charge and aptamer Kd.
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Introduction
Aptamers [1], [2] are nucleic acid-based affinity reagents
selected through an in vitro process that can bind to a range of
molecular targets, including small molecules, proteins, and cells
[3]. Aptamers offer a number of advantageous features, including
low cost, high thermal stability and the capacity for chemical
synthesis and modification, making them a promising alternative
to antibodies and other protein-based reagents [4]. However, due
to the iterative nature of the aptamer selection process (systematic
evolution of ligands by exponential enrichment; SELEX), the
generation of aptamers requires a significant investment of time,
labor and resources [5], and selections often fail to yield molecules
with affinities suitable for molecular diagnostics or therapeutics.
Thus, a selection technique that can efficiently and reproducibly
generate high performance aptamers is urgently needed.
Towards this end, our group recently reported a microfluidics-
based approach for the rapid generation of DNA aptamers.
Microfluidic SELEX (M-SELEX) exerts stringent selection
pressures by employing minimal amounts of target molecules
and continuous washing to isolate high affinity aptamers in fewer
rounds of selection compared to conventional methods [6], [7],
[8]. To extend this method, in this work, we report a universal M-
SELEX process that can isolate high affinity aptamers for a range
of protein targets with varying isoelectric points (pIs) within three
selection rounds. Using a common selection protocol, we have
discovered new aptamer sequences that bind to PDGF-BB [9] and
thrombin [10], [11] with higher affinities than those previously
published. We also report a new aptamer that binds apolipopro-
tein E3 [12], [13] with low nanomolar affinity. Based on the results
obtained from these selections, we make the observation that
target protein pI appears to be inversely related to the Kd of the
selected aptamers. To further explore this relationship, we
performed microfluidic selections with PDGF-BB under varying
pH conditions to alter its charge state, and report differences in the
affinities of the resulting aptamer pools.
Results
Microfluidic selection of aptamers
We performed DNA aptamer selections for three separate
protein targets under the same selection conditions. For every
round of selection, we used the micro-magnetic separation (MMS)
device [6] to efficiently separate non-specifically-bound DNA from
target-bound aptamers. For each target, we performed three
rounds of selection with increasing stringency (Fig. 1). This
stringency was controlled in two ways. First, we used a low
concentration of target protein during incubation and decreased
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27051this concentration after the first round of selection. Second, we
used a high flow rate during MMS washing and increased the
wash time to remove weakly- and non-specifically-bound DNA
(see Methods).
After three rounds of selection, the affinities of the enriched
aptamer pools were measured by a bead-based fluorescence assay
[6]. The selected pool for PDGF-BB (pI=9.3) showed the highest
affinity (Kd,bulk=0.10 nM) (Fig. 2A); the thrombin pool (pI=8.3)
showed moderate affinity (Kd,bulk=0.50 nM) (Fig. 2B); and the
ApoE pool (pI=5.3) displayed the lowest affinity
(Kd,bulk=9.3 nM) (Fig. 2C). These selection results reveal a clear
correlation between the bulk binding affinity of the enriched pools
and target protein isoelectric point (Fig. 2).
Identification of individual binding sequences
To obtain individual aptamer sequences for each target protein,
we cloned the round 3 pools into competent bacterial cells, and
randomly picked and sequenced twenty clones from each pool
(Table S1) using a method described previously [6]. We found that
the sequences for PDGF-BB and ApoE were all unique, indicating
that the round 3 pools were not fully converged. On the other
hand, with the exception of three orphan sequences, all of the
thrombin sequences belonged to one of two nearly identical
consensus groups, indicating that the pool had almost fully
converged. This differential rate of sequence convergence has also
been previously described. For example, the Bock thrombin
aptamer was obtained after only five rounds of selection [10],
while the Green PDGF aptamer required 12 rounds of selection
[9]. Despite differences in selection methods, this apparent
difference in convergence rates for individual targets suggests that
this phenomenon may arise from characteristics of the target
protein itself.
To rapidly identify the sequences with the highest affinities, we
measured the relative binding of each clone at a fixed
concentration with a bead-based fluorescence binding assay, and
rank-ordered the clones based on signal amplitude (Fig. 3). We
generated fluorescently-labeled sequences by PCR with an Alexa
Fluor 488-labeled forward primer, followed by lambda exonucle-
ase digestion. Based on the bulk binding affinities of the three
pools, we used a concentration of 0.5 nM to measure the PDGF-
BB and thrombin sequences, and 35 nM for the ApoE sequences.
The PDGF-BB clones showed a wide range of relative binding
affinities, reflecting the diversity of these sequences (Fig. 3A). The
round 3 thrombin pool was highly converged and, as expected, all
of the thrombin clones showed strong affinity except for two of the
orphan sequences (Fig. 3B). Interestingly, a single ApoE clone
showed significantly greater affinity compared to the other clones
at the concentration tested (Fig. 3C).
Characterization of selected sequences
We measured the Kd values of the sequences that exhibited the
highest relative binding: the three top sequences for PDGF-BB,
one sequence from each of the two consensus groups for thrombin
and the top binding ApoE sequence. We obtained binding
isotherms by the same bead-based fluorescence binding assay
described above, and fit the results by non-linear regression
(Table 1). These sequences all exhibited high affinities for their
targets and negligible binding to non-target proteins and uncoated
carboxylic acid beads (COOH) (Fig. 4). For example, our PDGF-
BB aptamer (PDGF-09) binds with a Kd of 0.028 nM (Fig. 4A)
which is significantly better than the previously reported aptamer,
which was obtained after 12 rounds of selection and reported to
have a Kd of 0.093 nM based on a filter-binding assay [9]. To
directly compare, we measured the affinity of this previously-
reported aptamer (Table S2) using our bead-based fluorescence
assay and obtained a Kd of 0.12 nM (Fig. S1).
The highest-affinity thrombin aptamer sequence (Thr-08)
obtained in this selection exhibits a Kd of 0.33 nM (Fig. 4B).
The affinity of this aptamer is better than those previously
reported by Bock [10] and Tasset [11] under the same
measurement conditions (Table S2). Using our assay, the Bock
and Tasset aptamers showed Kds of 1.2 nM and 11.9 nM,
Figure 1. Schematic showing the major steps of M-SELEX. The starting pool (1) is incubated with magnetic beads coated with the target
protein (2). After incubation, the sample is loaded onto the micro-magnetic separation (MMS) device, which traps the beads for high-stringency
washing (3). The eluted beads are then PCR-amplified to generate double-stranded DNA (4). The fluorescently-labeled forward strand is recovered
during a single-strand separation step (5), and can then be used for the next selection round, binding measurements (6) or cloning and sequencing
(7).
doi:10.1371/journal.pone.0027051.g001
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3.1 nM (Fig. 4C), and this sequence represents the first reported
DNA aptamer for this protein. To confirm the bead-based binding
measurements of the three aptamers, we performed binding
measurements using nitrocellulose filters with
32P-labeled apta-
mers (Fig. S3). The results of this solution-based method show
reasonable agreement with those of the bead-based assay.
Charge state of the target protein and aptamer affinity
Interestingly, when we examined the affinity of the selected
aptamers as a function of the isoelectric point (pI) of the target
protein, we observed a trend wherein aptamer affinity increased
with target pI. For example, the aptamer obtained in the selection
against ApoE, which has a pI of 5.3 and net negative charge,
displayed the lowest target affinity. The aptamer affinity was
somewhat higher for thrombin, a protein with a near-neutral pI
and small net positive charge, while aptamers against PDGF-BB,
which has the highest pI (9.3) and most positive net charge of the
three targets, exhibited the highest affinity. pIs were determined
computationally (see Methods) and then experimentally verified
using isoelectric focusing (Fig. S4).
Our capacity for rapid selection and affinity measurements
enabled us to further explore the relationship between the target
protein charge state and the affinity of the selected aptamers. We
performed three additional selections with PDGF-BB using
selection buffers spanning a range of pHs (4.6, 6.4, and 8.4) to
alter the net charge on the protein. The results show a clear link
between the net charge and the affinity of the resulting round 3
aptamer pool (Fig. 5). Selection at the higher pH of 8.4 (z=+8.1),
yielded an aptamer pool with lower affinity (Kd=0.22 nM)
relative to the selection performed at the physiological pH of 7.4
(z=+14.9; Kd=0.10 nM). On the other hand, the selection
performed at the lowest pH, 4.6 (z=+22.7), yielded the aptamer
pool with the highest affinity (Kd=0.044 nM). These results
provide evidence that a protein target’s net charge may influence
the affinity of the selected aptamers.
Discussion
In this work, we have demonstrated that M-SELEX provides a
highly efficient and broadly applicable platform for the selection of
high-affinity aptamers against a variety of protein targets. Using
this method, we performed selections against three different
proteins with pIs ranging from 9.3 to 5.3. Within three rounds of
selection, we obtained a new aptamer sequence that binds to
PDGF-BB with a Kd of 0.028 nM, and to thrombin with a Kd of
0.33 nM. These affinities are significantly higher than those
previously reported in the literature [9], [10], [11], which also
required considerably more rounds of selection to generate. We
also report a new aptamer targeting ApoE with a Kd of 3.1 nM.
The results obtained with these three targets suggest that the
target protein charge state may exert some degree of influence on
the overall affinity of the selected aptamer pool. To follow up on
this finding, we performed aptamer selections for PDGF-BB at
different buffer pHs using the same selection protocol which
revealed an apparent inverse correlation between protein pI and
aptamer Kd and therefore provided additional support for this
initial observation.
To explore whether this relationship between a protein’s charge
state and aptamer affinity potentially represents part of a broader
pattern, we plotted the Kds of 75 published aptamers (Table S3) as
a function of the pI of their target protein (Fig. 6). pI reflects the
average net charge of a protein and does not describe the spatial
charge distribution, but nevertheless offers a useful metric to make
a general observation of a trend. In this scatter plot, the
relationship between aptamer affinity and the protein’s isoelectric
point is not immediately obvious, presumably due to the
Figure 2. Affinities of round 3 pools for three target proteins.
Selections performed against three different proteins yielded enriched
aptamer pools whose binding affinities were dependent on pI as
determined by a bead-based fluorescence assay. (A) PDGF-BB round 3
pool Kd=0.10 nM. (B) Thrombin round 3 pool Kd=0.50 nM. (C) ApoE
round 3 pool Kd=9.3 nM.
doi:10.1371/journal.pone.0027051.g002
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measurement methods.
However, when we examined only the subset of aptamers with
Kd,1 nM, we observed a clear trend. For targets with pIs ranging
from 4.0 to 6.0, only 11% (2/19) of the resulting aptamers
exhibited subnanomolar affinity, but this percentage increased to
23% (3/13) for aptamers isolated against targets with pIs ranging
from 6.0 to 8.0 and to 35% (15/43) for aptamers against proteins
with a pI greater than 8.0. Based on this analysis, we observe
additional evidence for a relationship between the overall net
charge of a target protein and the affinity of aptamers selected
against that target.
Electrostatic surface potential maps of the three protein targets
selected here offer a potential explanation for this trend (Figure
S5); the protein with the highest proportion of positively-charged
surface area (PDGF-BB) yielded the highest affinity aptamer,
whereas the protein with the lowest proportion (ApoE) yielded the
lowest affinity aptamer. However, other physicochemical factors
such as size, structural complexity and intrinsic stability likely play
important roles in governing protein-aptamer interactions. Further
progress in the development of rapid selection techniques such as
the microfluidic approach described here should make it possible
to explore the relative impact of these target protein characteristics
in greater detail. In parallel, recent work exploring the
incorporation of non-natural bases into aptamers [14], [15]
suggests additional means by which one might use selection
strategies such as this to obtain molecules with yet higher affinity
for an even broader range of protein targets.
Figure 3. Screening of clones for target binding. We quantified the relative binding affinities of 20 clones from each selection using a bead-
based fluorescence binding assay at a single ssDNA concentration. NB indicates a non-binding control sequence included in each measurement. We
chose the top binding sequences for further analysis and determination of equilibrium dissociation binding constant (Kd). (A) PDGF-BB with
[ssDNA]=0.50 nM, NB=Thrombin Clone #1. (B) Thrombin with [ssDNA]=0.50 nM, NB=PDGF Clone #1. (C) ApoE with [ssDNA]=35 nM,
NB=Thrombin Clone #1.
doi:10.1371/journal.pone.0027051.g003
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DNA preparation
The single-stranded DNA (ssDNA) library, primers and selected
aptamer sequences were purchased from Integrated DNA
Technologies. The library was synthesized with hand mixing
and PAGE-purified. Each element of the 100-base random library
featured 60 randomized nucleotides flanked by two 20-base PCR
primer sites (59-AGCAGCACAGAGGTCAGATG-[60N]-
CCTATGCGTGCTACCGTGAA-39). Unlabeled and 59-modi-
fied PCR primers were obtained from Integrated DNA Technol-
ogies with HPLC purification. Fluorescein amidite (FAM)-labeled
versions of previously published aptamers (Table S2) were
obtained from Biosearch Technologies with HPLC purification.
Target preparation and verification
All proteins except thrombin (purchased from Haematologic
Technologies) were purchased from R&D Systems (carrier-free),
reconstituted in the appropriate selection buffer, and stored at
temperatures specified by the manufacturers. Protein immobiliza-
tion on M-270 carboxylic acid beads (Invitrogen) was performed
as described previously [6]. Surface coverage of the immobilized
protein was measured by the NanoOrange Protein Quantitation
kit (Invitrogen). The included bovine serum albumin (BSA)
standard was used to construct a calibration curve for each of
the three target proteins. Samples of Tris-blocked beads were
assayed in parallel, and those fluorescence values were subtracted
from the values obtained from the protein-coated beads. This
value was then converted to a protein concentration based on the
BSA calibration curve. To verify successful coupling, we measured
the protein concentration of the solution before and after coupling.
Device fabrication
The micro-magnetic separation (MMS) device was previously
developed by our group [6], [16]. Briefly, the device was
fabricated on borosilicate glass substrates with 25-mm-thick
double-coated tape (3 M). The micropattern was defined on the
bottom glass substrate with 20-nm-thick titanium and 200-nm-
thick nickel films using standard photolithography methods. Pitch
distances of 200, 100, and 50 mm were used in the nickel grid
pattern to provide increasing grid density. Fluidic vias were drilled
through the glass substrates using a computer-controlled CNC mill
and diamond bit (Abrasive Technology). After cleaning with
acetone, the Ti/Ni layer was passivated with a 100-nm-thick layer
of SiO2 by plasma-enhanced chemical vapor deposition (Plasma-
Therm). Microfluidic channels were cut out of the 25-mm-thick
double-sided tape using a plotting cutter (Graphtec). The
patterned tape was overlaid onto the top glass substrate manually.
The channel and micropattern were then manually aligned, and
the device was cured in an oven at 70uC overnight with light
clamping pressure. A brass eyelet was used as the buffer inlet, and
Tygon tubing (Saint-Gobain) was used for the sample inlet and
outlet fluidic connections. All connections were glued in place
using five-minute epoxy (Devcon). The external magnets consisted
of eight stacked neodymium magnets (K&J Magnetics), with
another magnet of the same type sandwiching the device to secure
it during the separation and washing steps.
Microfluidic SELEX
Aptamer selection for platelet-derived growth factor BB (PDGF-
BB) and apolipoprotein E3 (ApoE) was performed in phosphate-
buffered saline (PBS, pH 7.4) supplemented with 1 mM MgCl2
and 0.025% Tween 20. For the thrombin selection, the buffer
consisted of 50 mM Tris, 100 mM NaCl, 1 mM MgCl2,5m M
KCl, 1 mM CaCl2 and 0.025% Tween 20 at pH 7.5.
Before selection, target-coated beads were washed with selection
buffer three times. For the first round of SELEX, 1 nmol
(equivalent to ,6610
14 molecules) of library was heated to
95uC for 10 min, snap-cooled on ice, then brought to room
temperature and incubated with washed beads for 1 hour with
gentle rotation. Approximately 10
6 beads were used for the first
round, and half that amount for the second and third rounds. In
rounds 2 and 3, target-coated beads were blocked for 1 hour with
0.1 mM yeast tRNA (Invitrogen), then incubated for 1 hour with
100 pmole of snap-cooled ssDNA generated from the previous
round.
Following incubation, the sample was loaded into the MMS
device at 7 mL/hr through the top inlet with buffer flowing
through the bottom inlet at 3 mL/hr. The beads were then
washed at a combined flow rate of 50 mL/hr with selection buffer
for 6 minutes in the first round and 20 minutes in rounds 2 and 3,
after which the aptamer-bound beads were eluted from the MMS
device with 800 mL of selection buffer. The configuration of the
MMS device and pumps is shown in Figure S6. 10 mL of eluate
were amplified by pilot PCR to determine the optimal number of
rounds required for amplification without accumulating amplifi-
cation byproduct [6]. The eluted DNA was then PCR amplified
using a biotinylated reverse primer. This double-stranded DNA
(dsDNA) was purified with Qiagen minElute columns and the
concentration was measured by UV spectroscopy. Finally, we
generated ssDNA using the streptavidin-biotin method described
previously [6], [7], measured concentration by UV spectroscopy
and verified purity on a 4.5% low-melt agarose gel pre-stained
with GelStar (Lonza). For DNA pools that were to be assayed for
Table 1. The sequences of the top-binding aptamers and their affinities.
Clone ID Selected region (59 to 39) Kd (nM)
PDGF-01 CACGCGTACAAGTTGGGTGGAAGCATAGGCAATGAGCTCTCATTGGGTTACCTTTAAGGT 0.10
PDGF-08 GTTGCATATTGAGCATCGTGTAATGATCCTGCAAAGGCATTATGCATCGGGTCTTCCT 0.30
PDGF-09 GAATCATGATCCCCCATGACCTGGGGGCGTTACTGGCGAGCATCATGAGAGATCGTGCGA 0.028
Thr-02 TTGAAGTAATTTTATAGGTCTTTTATTGGGTAGGGTGGTTTTAATTGGTGTGACAAATTG 0.65
Thr-08 CAGCGCTAGGGCTTTTAGCGTAATGGGTAGGGTGGTGCGGTGCAGATATCGGAATTGGTG 0.33
ApoE-06 ACTAGCTACGGGGTGGGTGGGCGGTGTCAGTTTGTTTATTGGTGCTATACATCCTCTATA 3.1
Only the variable sequence (60-mer) is shown in the table, but affinity and specificity measurements were performed with full-length (100-mer) molecules containing
the flanking PCR primer-binding sites.
doi:10.1371/journal.pone.0027051.t001
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protein charge. The binding affinities (Kd) of selected round 3
aptamer pools are shown as a function of the pH of the selection buffer
(pH=4.6, 6.4, 7.4 and 8.4). Selection at pH 4.6 (z=+22.7) generated an
aptamer pool with the highest affinity (Kd=0.044 nM) whereas
selection at pH 8.4 (z=+8.1) yielded the pool with the lowest affinity
(Kd=0.22 nM). Calculations of net charge as a function of pH are
described in Methods.
doi:10.1371/journal.pone.0027051.g005
Figure 4. Affinity measurements of individual aptamer se-
quences for each protein target. (A) PDGF-09 binds to PDGF-BB
with Kd=0.028 nM, with negligible binding to bovine serum albumin-
coated (BSA) or uncoated beads (COOH). As a negative control, we
measured the binding of ApoE-06 to PDGF-BB. (B) Thr-08 binds to
thrombin with Kd=0.33 nM and shows negligible binding to BSA-
coated or uncoated beads. Binding of ApoE-06 to thrombin is minimal.
(C) ApoE-06 binds to ApoE with Kd=3.1 nM and shows negligible
binding to BSA-coated or uncoated beads. Thr-08 has minimal affinity
for ApoE.
doi:10.1371/journal.pone.0027051.g004
Figure 6. Aptamer affinity versus isoelectric point. A plot of
equilibrium dissociation constant (Kd) vs. isoelectric point (pI) for 75
published aptamers and the three newly discovered sequences from
this work. We observe an apparent inverse relationship between
protein pI and aptamer Kd. The proteins were identified in the UniProt
database and isoelectric points were determined from the Compute pI/
Mw tool at ExPASy.
doi:10.1371/journal.pone.0027051.g006
Protein’s Charge State and Aptamer Affinity
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PCR amplification. The selections against PDGF-BB at varying
pHs were performed as above, and buffer components were
identical except for the pH 4.6 selection, in which the buffering
agent was acetate.
Cloning and sequencing of selected aptamers
A small amount of DNA (250 pg) was amplified with unlabeled
primers, purified and cloned into chemically competent E. coli
using the TOPO TA Cloning Kit (Invitrogen). The transformed
bacteria were plated out and grown overnight at 37uC. Bacterial
colonies were sent for sequencing at GeneWiz. Individual clones
were amplified using a phosphorylated reverse primer and Alexa
Fluor 488-modified forward primer, then purified as above and
subjected to lambda exonuclease (New England Biosciences)
digestion to remove the phosphorylated strand and produce
ssDNA [17]. The resulting ssDNA was purified by phenol/
chloroform extraction and ethanol precipitated. ssDNA was
resuspended in Millipore water and its concentration measured
by UV spectroscopy. The purity was confirmed on a 4.5% low-
melt agarose gel stained with GelStar.
Characterization of aptamer binding affinity by
fluorescence bead assay
To measure the binding affinities of the selected pools and
sequences, we incubated a range of concentrations of Alexa Fluor
488-labeled ssDNA with target-coated beads for 1 hour at room
temperature with gentle rotation. Each sample was then washed
four times using a Magnetic Particle Concentrator (Invitrogen),
and the remaining bound DNA was eluted by incubation in
selection buffer at 95uC for 10 minutes. The amount of
fluorescence in the supernatant was measured with a microplate
reader (Tecan) and the background subtracted fluorescence values
were fit to a saturation binding curve using nonlinear regression
(assuming 1:1 binding) with Origin software (OriginLab). The top
binding clones in each selection were synthesized by Integrated
DNA Technologies with PAGE purification and prepared by PCR
for binding measurements with Alexa Fluor 488-labeled forward
primer and phosphorylated reverse primer. Exonuclease digestion,
subsequent purification, and DNA purity confirmation steps were
performed as described above.
Characterization of aptamer binding affinity by filter
binding assay
ssDNA to be assayed was end-labeled with [c-
32P]ATP (Perkin
Elmer) using T4 polynucleotide kinase (New England Biolabs) and
then purified with a G-25 spin column (GE Health Sciences). We
estimated the protein concentrations by absorbance at 280 nm
and calculated the extinction coefficients using ProtParam
(web.expasy.org/protparam/). We used mixed ester filters (Milli-
pore) for binding experiments with the thrombin and PDGF-BB
sequences. End-labeled DNA was snap cooled then incubated in
selection buffer with a range of protein concentrations for one
hour at room temperature with gentle rotation. The samples were
then pushed through pre-wetted filters mounted on holders
(Millipore). The filters were washed with 5 mL of buffer then
dried with 1 mL of air. We measured the radioactivity of the initial
sample, flow through, washes, and filter with a liquid scintillation
counter (Beckman Coulter). For the apolipoprotein E aptamer, we
used polyvinylidene fluoride (PVDF) membranes (GE Healthcare)
and performed the incubation in two steps. First, protein solution
was passed through the pre-wetted membrane and then the end-
labeled DNA was incubated with the membrane for one hour.
Background subtracted counts per minute (CPM) values were
fitted to a saturation binding curve using nonlinear regression
(assuming 1:1 binding) with Origin software (OriginLab).
Calculating and measuring protein isoelectric point
For the three proteins selected here (PDGF, thrombin and ApoE),
we calculated the pI and charge using pKa values from the European
Molecular Biology Open Software Suite (EMBOSS) based on amino
acid sequences obtained from UniProt (www.uniprot.org). pIs of
previously published aptamer protein targets were determined from
the Compute pI/Mw tool at ExPASy (web.expasy.org/compute_pi/)
using sequence information from UniProt.
Protein pIs were measured by isoelectric focusing (IEF). Pre-
cast, 24 cm IEF gels were purchased from GE Healthcare and
rehydrated with IPG buffer (GE Healthcare) and 1 mg of the
protein being measured according to the manufacturer’s instruc-
tions. The gels were run for 14.5 hours at 500 V and for 8.5 hours
at 3500 V on a Multiphor II electrophoresis system (GE
Healthcare). Afterwards, gels were stained with Sypro Ruby
(Invitrogen) and imaged using UV illumination. Band distances
were determined using ImageJ and corresponding pIs were
calculated from a piece-wise linear fit of the manufacturer’s
calibration curves.
Generation of electrostatic surfaces
Protein surface potentials were generated using PDB2PQR
(kryptonite.nbcr.net/pdb2pqr/) and the Adaptive Poisson-Boltz-
mann Solver (APBS) [18], and plotted with VMD [19].
Protonation states were determined using the computed net
charges and ionic conditions of the selection buffer and the
PARSE generated surface potentials were mapped to the van der
Waals surfaces. Thrombin structure 3F68 is shown for the protein
only without the ligand. 1PDG (PDGF-BB) is shown in dimer
form. 2L7B was used for ApoE.
Supporting Information
Figure S1 Affinity of a previously published aptamer to
PDGF-BB. Binding affinity of the previously published Green
aptamer [9] as measured using our bead-based fluorescence assay.
We obtained a Kd of 0.12 nM, which is similar to the original
published value (0.093 nM, based on a filter-binding assay).
(TIF)
Figure S2 Affinity of previously published aptamers to
thrombin. Bead-based fluorescence binding data of previously
published Bock [10] and Tasset [11] thrombin aptamers showing
measured Kds of 1.2 nM (A) and 11.9 nM (B), respectively.
(TIF)
Figure S3 Affinity of selected radiolabeled aptamers
based on filter binding. We determined the binding affinity of
the three selected aptamers by a filter binding assay. We measured
Kds for PDGF-BB-, thrombin- and ApoE-binding aptamers of
0.106 nM (A), 0.936 nM (B) and 9.25 nM (C), respectively.
(TIF)
Figure S4 Measuring the isoelectric points (pIs) of
PDGF-BB, thrombin and ApoE. We used isoelectric focusing
(IEF) to measure target protein pI directly for (A) PDGF-BB, (B)
thrombin and (C) ApoE under denaturing conditions for
comparison against calculated pIs. pIs were determined based
on band distance from the anodic end of the gel after focusing. For
thrombin, we observed two main bands in the region from 7 to
7.5, in agreement with previous results [20].
(TIF)
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27051Figure S5 Electrostatic potential surfaces of PDGF-BB,
thrombin and ApoE. The electrostatic potentials are mapped to
the van der Waals surfaces of these three proteins. The bottom set
of views show the proteins rotated 180u about the vertical axis.
These three maps suggest a structural basis for the relationship
between charge and binding affinity. Reflecting its high net
positive charge (z=+15), a substantial portion of the PDGF-BB
homodimer surface has a highly positive surface potential. These
regions present sizable areas for possible interactions with the
highly negatively charged DNA aptamers, and were identified as
the actual binding sites for a previously-isolated PDGF-AB
aptamer through cross-linking experiments [9]. Thrombin
(z=+2.6) contains two somewhat smaller distinct regions of
positive surface potential, and these were also identified as the
binding sites of two previously-published thrombin aptamers [10],
[11]. The surface potential of ApoE (z=24.3) is more
heterogeneous, reducing the area available for aptamer binding.
These data support the view that aptamers often preferentially
bind to positively charged surface patches, as has been observed in
crystal structures of aptamers bound to proteins [21], [22], [23],
[24], [25], [26].
(TIF)
Figure S6 Schematic of micro-magnetic separation
(MMS) device and pump configuration. The organization
of the fluidic connections between the pumps and MMS chip are
shown. Syringe pumps (not shown) were used to infuse buffer
solution.
(TIF)
Table S1 Selected sequences. 60-mer random regions cloned
from each selected round 3 pool.
(DOCX)
Table S2 Sequences of previously published aptamers.
We synthesized these aptamer sequences with a 59-FAM
fluorophore and assayed their binding affinity using the bead-
based method.
(DOCX)
Table S3 A list of 75 previously published aptamers.
This list was compiled from PubMed searches and includes both
RNA and DNA aptamers against protein targets. Where not
provided in the reference, isoelectric points were determined by
UniProt (www.uniprot.org) and ExPASy (www.expasy.org).
(DOCX)
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